Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-549
TNBC
Basal B
XRP44X
ELK3
MAPK
12305.157
uM
1.46020
1.22050
0.2279 0.2960 5.0000 0.3010
0.9051
2.9955
BT-549
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
7803.011
uM
33.04150
53.67520
-0.6366 -0.6683 1.7492 0.4207
0.9973
3.0094
BT-549
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
7803.011
uM
0.00759
0.00979
-0.2571 -0.2190 1.4280 0.9010
0.9933
3.0094
BT-549
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
7803.011
uM
2.02090
6.22230
-0.7341 -0.7799 0.8358 0.6413
0.9903
3.0094
BT-549
TNBC
Basal B
GM6001
MMP
MMP
5909.096
uM
inf
5.95550
0.8966 0.8697 0.7287 0.0248
0.7038
3.0117
BT-549
TNBC
Basal B
QNZ
NFkB
NFKB
5909.096
uM
inf
0.01255
0.7939 0.8094 0.8368 0.1153
0.8079
3.0117
BT-549
TNBC
Basal B
TAPI-0
TACE/Collagenase
5909.096
uM
inf
4.6090
0.8816 0.8803 2.2975 0.0095
0.7446
3.0117
MCF 10A
NM
Basal B
Methylglyoxal
13551.184
uM
680.90370
999.99950
-0.2926 -0.2104 0.9138 0.3902
0.9470
3.0171
MCF 10A
NM
Basal B
ZM-447439
AURK
AURK
11056.15
uM
inf
0.46426
0.6809 0.6831 2.5666 0.1026
0.9909
3.0207
MCF 10A
NM
Basal B
Glycyl-H-1152
ROCK2
11056.15
uM
inf
2.34330
0.5757 0.5710 2.1336 0.0938
0.9859
3.0207
MCF 10A
NM
Basal B
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
11056.15
uM
4.25490
9.16210
0.2253 -0.1815 0.4037 0.2101
0.9544
3.0207
SUM159PT
TNBC
Basal B
Cetuximab
EGFR
ErbB
7918.018
uM
inf
inf
0.9278 0.9278 0.0000 0.0321
0.1456
3.0213
SUM159PT
TNBC
Basal B
CGC-11047
Polyamine analogue
7918.018
uM
113.81230
620.84460
-0.5727 -1.0000 0.6476 0.4014
0.9793
3.0213
SUM159PT
TNBC
Basal B
Vinorelbine
TUBB
TUBB
7918.018
uM
0.00074
0.00109
-0.5523 -0.3456 1.3735 1.1044
0.9653
3.0213
BT-549
TNBC
Basal B
MG-132
Proteasome
Proteasome
14122.189
uM
0.14922
0.16636
-0.8306 -0.3612 5.0000 0.6812
0.6090
3.0232
BT-549
TNBC
Basal B
MG-132
Proteasome
Proteasome
14122.189
uM
0.14922
0.16636
-0.8306 -0.3612 5.0000 0.6812
0.6090
3.0232
BT-549
TNBC
Basal B
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14122.189
uM
0.44048
0.52843
-0.7285 -0.7424 5.0000 0.6618
0.9973
3.0232
MCF 10A
NM
Basal B
ICRF-193
TOP2
TOP
11056.151
uM
inf
0.04801
0.5349 0.5474 2.0247 0.2393
0.9850
3.0292
MCF 10A
NM
Basal B
XRP44X
ELK3
MAPK
11056.151
uM
0.35713
0.35089
0.0205 0.0422 5.0000 0.4286
0.9989
3.0292
BT-549
TNBC
Basal B
Erlotinib
EGFR
ErbB
5909.092
uM
64.86970
405.03060
0.6245 -0.9999 0.5998 0.0549
0.9591
3.0314
BT-549
TNBC
Basal B
GSK1838705A
IGF1R
RTK
5909.092
uM
5.07990
6.30740
-0.7169 -0.7170 4.1102 0.3216
0.9990
3.0314
BT-549
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
5909.092
uM
36.52830
49.83120
-0.7507 -0.7525 2.9569 0.3310
0.9990
3.0314
BT-549
TNBC
Basal B
AG1024
IGF1R
RTK
5909.066
uM
inf
inf
0.9667 0.9667 0.0000 -0.0279
-0.7876
3.0464
BT-549
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
5909.066
uM
inf
34.75420
0.6171 0.5024 1.8452 0.0287
0.9686
3.0464
MCF 10A
NM
Basal B
GSK1838705A
IGF1R
RTK
7483.091
uM
5.84960
6.37170
-0.4695 -0.2667 5.0000 0.3192
0.9527
3.0465